PProgram in detamil Day 1. Sep.2(Thu) Day 2. Sep.3(Fri) Day 3. Sep.4(Sat) Sep.2(Thu) Pre-Congress Symposium 1 (KOR) 15:30-17:00 National Obesity Strategy in The Era of COVID-19 Room 1 Kyoung-Kon Kim (External Affairs and Policy) 15:30-15:40 ( ) Session 1. 15:40-16:05 ( ) 16:05-16:20 ( ) ( ) Session 2. 16:20-16:45 , ( ) 16:45-17:00 ( ) ( ) Sep.2(Thu) Satellite Symposium 1 (Daiichi-Sankyo) 19:00-20:00 Room 1 Sung Rae Kim (The Catholic University of Korea, Korea) Prevention of CVD in Hypertension with Diabetes Mellitus Youngwoo Jang (Gachon University, Korea) Sep.2(Thu) Satellite Symposium 2 (Boehringer Ingelheim) 19:00-20:00 Room 2 Seon Mee Kim (Korea University, Korea) How to Approach Patients with Type 2 Diabetes in Perspective of Cardio-Renal Metabolism and Current Treatment Algorithm Chantal Mathieu (Medicine at the Katholieke Universiteit and Chair of Endocrinology at the University Hospital Gasthuisberg Leuven, Belgium) PProgram in detamil Day 1. Sep.2(Thu) Day 2. Sep.3(Fri) Day 3. Sep.4(Sat) Sep.3(Fri) Breakfast Symposium 1 (LG Chem) 07:30-08:00 Room 1 Sang Yeoup Lee (Pusan National University, Korea) The Renoprotective Effect and Safety of Gemigliptin for Type 2 Diabetes Jun Hwa Hong (Eulji University, Korea) Sep.3(Fri) Breakfast Symposium 2 (SANOFI) 07:30-08:00 Room 2 Sung Soo Kim (Chungnam National University, Korea) The Korean Titration Study: Simple & Easy Titration Method for Glargine 300 Young Min Cho (Seoul National University, Korea) Sep.3(Fri) Keynote Lecture 1 08:15-08:55 Room 1 + Room 2 + Room 3 Chang Beom Lee (Chairman of Korean Society for the Study of Obesity, Korea) Background and Results of STEP 6 Study on Efficacy and Safety of Semaglutide in Japanese and Korean Takashi Kadowaki (Toranomon Hospital, Federation of National Public Service Personnel Mutual Aid Associations, Japan) Sep.3(Fri) Symposium 1 09:00-10:30 Obesity and Cardiovascular Disease Room 1 Young Seol Kim (Kyung Hee University, Korea) Kee-Ho Song (Konkuk University, Korea) 09:00-09:30 Kartell of Death: Visceral Obesity and Cardiovascular Disease Carl (Chip) J. Lavie (Louisiana State University, USA) 09:30-10:00 Cardiovascular Risk: Variability Matters Kyung Mook Choi (Korea University, Korea) 10:00-10:30 CV Risk in Metabolically Healthy Obesity Changhee Jung (University of Ulsan, Korea) Sep.3(Fri) Symposium 2 09:00-10:30 Gut Microbiome, Obesity and Metabolic Disorders Room 2 GwangPyo Ko (Seoul National University, Korea) Soon Jib Yoo (The Catholic University of Korea, Korea) 09:00-09:30 Roles of Gut Microbes In The Pathogenesis and Development of Obesity, NAFLD, and Diabetes: A Systems Perspective Hao Wu (Fudan University, China) 09:30-10:00 Global and Temporal State of Human Microbiome in Health and Disease Sunjae Lee (Gwangju Institute of Science and Technology, Korea) 10:00-10:30 Multiomics Approach for Targeting Novel Microbiome Therapeutics Against Metabolic Diseases GwangPyo Ko (Seoul National University, Korea) Sep.3(Fri) Symposium 3 09:00-10:30 Novel Mechanistic Insights of Appetite and Weight Control Room 3 Ki Woo Kim (Yonsei University, Korea) Min-Seon Kim (University of Ulsan, Korea) 09:00-09:30 The Role of The Hypothalamic Cereblon (CRBN) in The Control of Feeding Behavior and Body Weight Jaemin Lee (DGIST, Korea) 09:30-10:00 Long-Term Increase of AgRP Neuron Activity Causes Body Weight Gain without Affecting Food Intake Jong-Woo Sohn (KAIST, Korea) 10:00-10:30 Algorithms for Appetite Sco Sternson (UCSD, USA) Sep.3(Fri) Symposium 4 09:00-10:30 Socioeconomic Inequalities in Obesity Epidemiology Room 4 Kyoung-Kon Kim (Gachon University, Korea) Yang Im Hur (Inje University, Korea) 09:00-09:30 Socioeconomic Differentials in Obesity in Australia Mark Harris (Centre for Primary Health Care and Equity, UNSW, Australia) 09:30-10:00 Socioeconomic and Gender Inequalities in Obesity in Taiwan Wen-Harn Pan (Institute of Biomedical Sciences Academia Sinica Taipei, Taiwan) 10:00-10:30 Trends in Socioeconomic Inequalities in Major Risk Factors for Cardiovascular Disease in Korea Sin Gon Kim (Korea University, Korea) Sep.3(Fri) Sponsored Session 1 (MSD) 09:00-10:30 Strategies to Provide Better Life for Type 2 Diabetes Patients Room 5 Sang-Ah Chang (The Catholic University of Korea) 09:00-09:35 Keep Your Confidence on Type 2 DM in Broad Range of Patients So Hun Kim (Inha University, Korea) 09:35-10:10 The Latest Evidence of SGLT2 Inhibitors for Patients with Type 2 Diabetes Suk Chon (Kyung Hee University, Korea) 10:10-10:30 Discussion Sep.3(Fri) Opening Address 10:40-10:45 Room 1 + Room 2 + Room 3 Jae-Heon Kang (President of Korean Society for the Study of Obesity, Korea) Sep.3(Fri) Plenary Lecture 1 Room 1 + Room 2 + Room 3 10:45-11:25 Young Kil Choi (Kyung Hee University, Korea) Implication of Obesity in Cardiometabolic Risk Robert H. Eckel (University of Cololado Anschutz Medical Center, USA) Sep.3(Fri) Oral Presentation 1 Room 4 11:30-12:30 Jun Sung Moon (Yeungnam University, Korea) Ji Won Yoon (Seoul National University, Korea) Jin-Wook Kim (Uijeongbu Eulji Medical Center, Korea) Sarah Woo (Hallym University, Korea) Akinkunmi Okekunle (Seoul National University, Korea) Soo Lim (Seoul National University Bundang Hospital, Korea) Gyu Bae Lee (Korea University College of Medicine, Korea) Premkumar Natraj (Jeju National University, Korea) Sep.3(Fri) Oral Presentation 2 Room 5 11:30-12:30 Young-Jun Rhie (Korea University, Korea) Jang Won Son (The Catholic University of Korea, Korea) Janice Ee Fang Tay (UCSI University, Malaysia) Kyung Jae Lee (Hallym University College of Medicine, Korea) Shindy Soedono (Soonchunhyang University, Korea) Ji-Hyeon Park (Seoul National University Hospital, Korea) Minji Sohn (Seoul National University Bundang Hospital, Korea) Yong Hyun Park (The catholic University of Korea, Korea) Sep.3(Fri) Luncheon Symposium 1 (Alvogen) Room 1 12:40-13:40 Soon Jib Yoo (The Catholic University of Korea, Korea) Long-Term Efficacy & Safety on Combination Phentermine Plus Topiramate ER : Where Do We Stand? Tae Jung Oh (Seoul National University, Korea) Sep.3(Fri) Luncheon Symposium 2 (MSD) Room 2 12:40-13:40 Jeong-Taek Woo (Kyung Hee University, Korea) Individualized T2DM Treatment Focus on Recent Treatment Option Jae Hyuk Lee (Hanyang University, Korea) Sep.3(Fri) Luncheon Symposium 3 (DAEWOONG) Room 3 12:40-13:40 Jae-Heon Kang (President of Korean Society for the Study of Obesity, Korea) Glycemic Variability: Glycemic Control for Reversing Diabesity Ji-Won Lee (Yonsei University, Korea) Sep.3(Fri) Luncheon Symposium 4 (Chong Kun Dang Pharm) Room 4 12:40-13:40 Soon Jib Yoo (Catholic University of Korea, Korea) Long-Term Efficacy & Safety on Combination Phentermine Plus Topiramate ER : Where Do We Stand? Tae Jung Oh (Seoul National University, Korea) Sep.3(Fri) Symposium 5 13:40-15:10 Obesity Drug Room 1 Sang Woo Oh (Dongguk University, Korea) Kyung Hee Park (Hallym University, Korea) 13:40-14:10 Role of Amylin Analogues in Obesity Management Carel le Roux (University College Dublin, Ireland) 14:10-14:40 Obesity Control with SGLT2i and GLP1RA Combination Therapy Jun Hwa Hong (Eulji University, Korea) 14:40-15:10 Patient-Centered Anti-Obesity Medication Sang Yeoup Lee (Pusan National University, Korea) Sep.3(Fri) Symposium 6 13:40-15:10 New Paradigm for Clinical Nutrition on Obesity (Untact) Room 2 Cho-il Kim (Seoul National University, Korea) Kyeong Sook Yim (Suwon University, Korea) 13:40-14:10 Get Cooking: Tele-Nutrition for Managing Obesity and Metabolic Diseases Rani Polak (Institute of Lifestyle Medicine, USA) 14:10-14:40 Online eLearning Nutrition Education and Obesity Prevention for Low-Income Adults: Experiences from the University of Georgia Supplemental Nutrition Assistance Program Education (UGA SNAP-Ed) Jung Sun Lee (University of Georgia, USA) 14:40-15:10 A New Paradigm for Clinical Nutrition Services in The Era of The Fourth Industrial Revolution Jung-Sook Seo (Yeungnam University, Korea) Sep.3(Fri) Symposium 7 13:40-15:10 COVID-19 and Obesity Room 3 Kwan Woo Lee (Ajou University, Korea) You-Cheol Hwang (Kyung Hee University, Korea) 13:40-14:10 Dissecting The Risk Factor of Severe COVID-19 Patients with Obesity and Metabolic Disorders Jae-Han Jeon (Kyungpook National University, Korea) 14:10-14:40 Management of Obesity-Lessons Learnt from COVID-19 Alice Pik Shan Kong (The Chinese University of Hong Kong, China) 14:40-15:10 COVID-19 Vaccination and Obesity Won Suk Choi (Korea University, Korea) Sep.3(Fri) Symposium 8 13:40-15:10 Bariatric Surgery Room 4 Yong Jin Kim (H Plus Yangji Hospital, Korea) Youn-baik Choi (University of Ulsan, Korea) 13:40-14:10 Endoscopic Bariatric Procedures Silvana Perre (Research Institute against Digestive Cancer IRCAD, France) 14:10-14:40 Prediction Model for Chronological Weight Loss after Bariatric Surgery in Korean Patients Ji Yeon Park (Kyungpook National University, Korea) 14:40-15:10 Diabetes Remission after Sleeve Plus Procedure in Korean Patients Yong Jin Kim (H Plus Yangji Hospital, Korea) Sep.3(Fri) Sponsored Session 2 (Alvogen) 13:40-15:10 Is Obesity A Comorbid Disease? Room 5 Kiyoung Lee (Gachon University, Korea) 13:40-14:10 The Efficacy & Safety of Combination Phentermine Plus Topiramate ER for Obese Patients with Hypertension and Hyperlipidemia Hyuktae Kwon (Seoul National University, Korea) 14:10-14:40 The Efficacy and Safety of Combination Phentermine Plus Topiramate ER for Obese Patients with Type 2 Diabetes Mellitus Wonjin Kim (CHA University, Korea) 14:40-15:10 The Benefits of Prescribing Combination Phentermine Plus Topiramate ER for Obese Patient from The Clinician’s